HUTCHMED (China) And Innovent's Endometrial Cancer Treatment Granted Priority Review By NMPA
(RTTNews) - HUTCHMED (China) Limited (HCM) and Innovent Biologics Inc. said that the China National Medical Products Administration or 'NMPA' has ...
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - HUTCHMED (China) Limited (HCM) and Innovent Biologics Inc. said that the China National Medical Products Administration or 'NMPA' has ...
- Positive HTA recommendation for reimbursement signifies an important milestone towards public funding to treat eligible patients with this rare liver disorder - LIVMARLI is the first and only...
AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment.
AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US. The Cambridge, England-based pharmaceutical company said that its Voydeya treatment had been...
A9026i FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or...